Summit Trail Advisors, LLC Ptc Therapeutics, Inc. Transaction History

Summit Trail Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$33.9 - $47.77 $18,645 - $26,273	-550 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$25.7 - $47.88 $397,553 - $740,655	-15,469 Reduced 96.57%	550 $19,000
Q1 2018 May 21, 2018	BUY	$17.46 - $32.59 $268,691 - $501,527	15,389 Added 2442.7%	16,019 $16,000
Q4 2017 Feb 14, 2018	BUY	$15.14 - $20.89 $9,538 - $13,160	630	630 $13,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.